What does Moderna do?

Moderna, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2010. The company specializes in messenger RNA (mRNA) technology to develop medicines and vaccines for various conditions, including infectious diseases, cancer, and rare genetic disorders. Originally named ModeRNA Therapeutics, Moderna has gained significant recognition for its COVID-19 vaccine, mRNA-1273, which was authorized for emergency use in December 2020. Moderna's innovative mRNA platform allows for the rapid development of treatments and vaccines by instructing cells to produce therapeutic proteins. The company has a diverse pipeline that includes candidates for infectious diseases like influenza and Zika, personalized cancer vaccines in collaboration with Merck, and treatments for rare diseases such as cystic fibrosis. Moderna has established partnerships with several pharmaceutical companies and agencies to advance its mRNA research and expand its therapeutic offerings. The company operates a manufacturing facility in Norwood, Massachusetts, and continues to grow its research capabilities.